Kalytera Initiates Program to Develop a Novel Cannabinoid-Based Compound for Treatment of Acute and Chronic Pain Read more
Chronic pain and therapeutic opportunities, exploring CNTX-6970’s case study and the role of Big Data in drug discovery and development Read more